Appointment of Sole Corporate Broker

Summary by AI ^BETAClose X

Fevara plc, an international specialist in livestock supplements, has appointed Canaccord Genuity Limited as its Sole Corporate Broker, effective immediately. This announcement is significant as it indicates a strategic move to enhance the company's financial advisory and market engagement capabilities.

Disclaimer*

Fevara PLC

02 February 2026

2 February 2026

Fevara plc

Appointment of Sole Corporate Broker

Fevara plc (LSE: FVA), an international specialist in livestock supplements, is pleased to announce the appointment of Canaccord Genuity Limited as Sole Corporate Broker, with immediate effect.

For further information, please contact:


Fevara plc	+44 (0) 1228 554 600
Joshua Hoopes, Chief Executive Officer Gavin Manson, Chief Financial Officer

Canaccord Genuity Limited (Corporate Broker)	+44 (0)20 7523 8000
Max Hartley / Harry Rees


Hudson Sandler (PR Adviser)	+44 (0) 20 7796 4133
Hattie Dreyfus / Nick Moore

About Fevara plc:

Fevara is an international specialist in livestock supplements.

Fevara's purpose is to empower farmers in extensive grazing systems with research-proven products that boost profitability, improve resource efficiency and support sustainable agriculture. The Group develops, manufactures and markets research-proven supplements, including feed licks, blocks, bagged minerals, and boluses for cattle, sheep and horses, sold under recognised and trusted brands, including Crystalyx^®, HorsLic^®_, Horslyx^®, Scotmin Nutrition^®, SmartLic^® and Tracesure® Advanced.

Headquartered in Carlisle, Cumbria, in the UK, Fevara has five manufacturing sites in the UK, US and Brazil with three operational joint ventures in Germany and the US. It serves customers in more than 20 countries through its expansive international distribution and support network.

Fevara has been listed on the London Stock Exchange since 1972.

For more information, visit: www.fevara.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END